Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

intrepidity

(7,290 posts)
Thu Jul 1, 2021, 03:29 PM Jul 2021

Science: "SARS-CoV-2 immune evasion by the B.1.427/B.1.429 VOC" (California "epsilon")

So I guess the question is how significant a 2-3 fold reduction in neutralizing antibodies is, clinically.

(Pfizer and Moderna)

https://science.sciencemag.org/content/early/2021/06/30/science.abi7994?

Abstract
A novel variant of concern (VOC) named CAL.20C (B.1.427/B.1.429), originally detected in California, carries spike glycoprotein mutations S13I in the signal peptide, W152C in the N-terminal domain (NTD), and L452R in the receptor-binding domain (RBD). Plasma from individuals vaccinated with a Wuhan-1 isolate-based mRNA vaccine or convalescent individuals exhibited neutralizing titers, which were reduced 2-3.5 fold against the B.1.427/B.1.429 variant relative to wildtype pseudoviruses. The L452R mutation reduced neutralizing activity of 14 out of 34 RBD-specific monoclonal antibodies (mAbs). The S13I and W152C mutations resulted in total loss of neutralization for 10 out of 10 NTD-specific mAbs since the NTD antigenic supersite was remodeled by a shift of the signal peptide cleavage site and formation of a new disulphide bond, as revealed by mass spectrometry and structural studies.


The incidence of the B.1.427/B.1.429 lineages is increasing rapidly
The SARS-CoV-2 B.1.427/B.1.429 variant was reported for the first time at the beginning of 2021 in California and as of May 2021 has been detected in 34 additional countries (41, 42). The two lineages B.1.427 and B.1.429 (belonging to clade 20C according to Nextstrain designation) share the same S mutations (S13I, and W152C in the NTD and L452R in the RBD), but harbor different mutations in other SARS-CoV-2 genes (42). Molecular clock analysis suggest that the progenitor of both lineages emerged in May 2020, diverging to give rise to the B.1.427 and B.1.429 lineages in June-July 2020 (42). The fast rise in the number of cases associated with the B.1.427/B.1.429 lineages led to their classification as a VOC by the US Center for Disease Control


These findings show that the three mutations present in the B1.427/B.1.429 S glycoprotein decrease the neutralizing activity of vaccine-elicited and infection-elicited Abs, suggesting that these lineage-defining residue substitutions are associated with immune evasion. However, these data also underscore the higher quality of Ab responses induced by vaccination compared to infection and their enhanced resilience to mutations found in VOC.


Collectively, these findings demonstrate that the S13I and W152C mutations found in the B.1.427/B.1.429 S variant are jointly responsible for escape from NTD-specific mAbs, due to deletion of the SARS-CoV-2 S two N-terminal residues and overall rearrangement of the NTD antigenic supersite. Our data support that the SARS-CoV-2 NTD evolved a compensatory mechanism to form an alternative disulfide bond and that mutations of the S signal peptide occur in vivo in a clinical setting to promote immune evasion. The SARS-CoV-2 B.1.427/B.1.429 S variant therefore relies on an indirect and unusual neutralization-escape strategy.

7 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Science: "SARS-CoV-2 immune evasion by the B.1.427/B.1.429 VOC" (California "epsilon") (Original Post) intrepidity Jul 2021 OP
So I am not Science smart--If I barely grasp this the Epsilon Variant basically makes PA_jen Jul 2021 #1
This variant reduces (by 2-3 fold) one immune respone intrepidity Jul 2021 #2
I've read delta reduces vax efficacy by 6 fold SheltieLover Jul 2021 #3
Yeah, delta makes me nervous. nt intrepidity Jul 2021 #4
Have you seen Harvard epidemiologist, Dr. Dingel's tweets? 😰 SheltieLover Jul 2021 #5
Will check that out later, thanks intrepidity Jul 2021 #6
Ok. SheltieLover Jul 2021 #7

PA_jen

(1,114 posts)
1. So I am not Science smart--If I barely grasp this the Epsilon Variant basically makes
Thu Jul 1, 2021, 04:10 PM
Jul 2021

the vaccines mute against it?

intrepidity

(7,290 posts)
2. This variant reduces (by 2-3 fold) one immune respone
Thu Jul 1, 2021, 04:21 PM
Jul 2021

that of neutralizing antibodies. Its mutations are in regions that are targeted by the vaccines.

It"s not clear how much difference that 2-3x means, clinically--whether the vaccines elicit such a robust immune response that the decrease won't matter.

SheltieLover

(57,073 posts)
5. Have you seen Harvard epidemiologist, Dr. Dingel's tweets? 😰
Thu Jul 1, 2021, 05:23 PM
Jul 2021

#4 in thread here. Rhiannon graciously compiled & posted for us.

I bought 2 new boxes of 3M N95 9002s, before they sell out, after reading this.

Spoiler: delta more contageous than smallpox & cloth masks are not good enough to protect against delta!

https://www.democraticunderground.com/100215572903

Makes me extremely nervous CDC is not reporting breakthrough infections.

intrepidity

(7,290 posts)
6. Will check that out later, thanks
Thu Jul 1, 2021, 06:01 PM
Jul 2021

I'm aware of some of that info but not certain of source.

I have tons of masks still, and have no plans to stop using them! If for no other reason than it's been awfully nice not having even one slightest cold for over a year!

Latest Discussions»Culture Forums»Science»Science: "SARS-CoV-2 immu...